Explore the words cloud of the EDIT project. It provides you a very rough idea of what is the project "EDIT" about.
The following table provides information about the project.
Coordinator |
OSPEDALE SAN RAFFAELE SRL
Organization address contact info |
Coordinator Country | Italy [IT] |
Project website | https://www.edit-h2020.eu/ |
Total cost | 4˙317˙160 € |
EC max contribution | 4˙317˙160 € (100%) |
Programme |
1. H2020-EU.1.2.1. (FET Open) |
Code Call | H2020-FETOPEN-1-2016-2017 |
Funding Scheme | RIA |
Starting year | 2018 |
Duration (year-month-day) | from 2018-10-01 to 2022-09-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | OSPEDALE SAN RAFFAELE SRL | IT (MILANO) | coordinator | 1˙146˙963.00 |
2 | FUJIFILM SONOSITE BV | NL (AMSTERDAM) | participant | 681˙625.00 |
3 | UNIVERSITA DEGLI STUDI DI MILANO | IT (MILANO) | participant | 480˙125.00 |
4 | ASCEND TECHNOLOGIES LIMITED | UK (SOUTHAMPTON) | participant | 400˙500.00 |
5 | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA | IT (BOLOGNA) | participant | 374˙350.00 |
6 | CONSIGLIO NAZIONALE DELLE RICERCHE | IT (ROMA) | participant | 368˙437.00 |
7 | WEIZMANN INSTITUTE OF SCIENCE | IL (REHOVOT) | participant | 350˙225.00 |
8 | LIME TECHNOLOGY IKE | EL (IOANNINA) | participant | 298˙570.00 |
9 | OSM-DAN LTD | IL (REHOVOT) | participant | 216˙363.00 |
Unmet clinical needs in the management of bladder cancer (BCa) are the prevention of tumor onset, relapse and progression, and therapy of the aggressive carcinoma in situ (Cis), requiring weekly treatments and endless follow-up, with a consequent poor quality of life and the highest cost per patient among all cancers. Therefore, public health programs crave for early BCa detection protocols, to improve performance in the management of this devastating disease. Here we propose an advanced transformative technology termed EDIT combining a novel high-resolution ultrasound elastography and photoacoustic imaging on the bladder instilled with targeted plasmonic gold sensors. EDIT approach exploits the structural and mechanical properties of the bladder extracellular matrix (ECM) as a unique biomarker of the early onset/progression/relapse of carcinoma, through engineered novel gold nanorods (GNRs) used as intravesical photoacoustic antennas targeted at the ECM, generating an ad hoc visualization platform. GNRs will be further utilized as heat-releasing effectors at nanoscale for targeted cancer photo-thermal therapy. EDIT is designed to detect pre-neoplastic area and eradication of local areas at few cells resolution with high sensitivity and specificity. We bring together a multi and transdisciplinary consortium capable to develop non-invasive and non-ionizing novel technology and preclinical validation for early prognosis of BCa and therapeutic nanomedicine against bladder Cis. Outcomes of EDIT will revolutionize the management of BCa with the introduction of sensing and effector nanotechnologies combined with non-invasive organ imaging with high resolution/definition by 3D ultrasound and photoacoustic imaging. Structural and mechanical modification of the ECM is a common denominator for invasive breast, colorectal, prostate and bladder cancers. EDIT platforms will also pave the ways for the earlier management of other bladder-related pathologies and solid tumors.
First plan for dissemination and exploitation (using and disseminating the foreground (=PUDF)) | Documents, reports | 2020-02-12 17:34:02 |
Project website and logo | Websites, patent fillings, videos etc. | 2020-02-12 17:34:07 |
Take a look to the deliverables list in detail: detailed list of EDIT deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
Mark Owyong, Jonathan Chou, Renske JE van den Bijgaart, Niwen Kong, Gizem Efe, Carrie Maynard, Dalit Talmi-Frank, Inna Solomonov, Charlotte Koopman, Elin Hadler-Olsen, Mark Headley, Charlene Lin, Chih-Yang Wang, Irit Sagi, Zena Werb, Vicki Plaks MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy published pages: e201800226, ISSN: 2575-1077, DOI: 10.26508/lsa.201800226 |
Life Science Alliance 2/6 | 2020-04-15 |
2020 |
Mordehay Klepfish, Tamar Gross, Milena Vugman, Nikolaos A. Afratis, Sapir Havusha-Laufer, Eli Brazowski, Inna Solomonov, Chen Varol, Irit Sagi LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2020.00480 |
Frontiers in Immunology 11 | 2020-04-15 |
2019 |
Francesca Nardelli, Michela Ghitti, Giacomo Quilici, Alessandro Gori, Qingqiong Luo, Andrea Berardi, Angelina Sacchi, Matteo Monieri, Greta Bergamaschi, Wolfgang Bermel, Fuxiang Chen, Angelo Corti, Flavio Curnis, Giovanna Musco A stapled chromogranin A-derived peptide is a potent dual ligand for integrins αvβ6 and αvβ8 published pages: , ISSN: 1359-7345, DOI: 10.1039/c9cc08518a |
Chemical Communications | 2019-12-16 |
2019 |
Alakesh Das, Vishnu Mohan, Venkat Raghavan Krishnaswamy, Inna Solomonov, Irit Sagi Exosomes as a storehouse of tissue remodeling proteases and mediators of cancer progression published pages: , ISSN: , DOI: 10.1007/s10555-019-09813-5 |
Cancer and Metastasis Reviews | 2019-12-16 |
2019 |
Mirko Maturi, Erica Locatelli, Ilaria Monaco, Mauro Comes Franchini Current concepts in nanostructured contrast media development for in vivo photoacoustic imaging published pages: 1746-1775, ISSN: 2047-4830, DOI: 10.1039/c8bm01444b |
Biomaterials Science 7/5 | 2019-10-01 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EDIT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EDIT" are provided by the European Opendata Portal: CORDIS opendata.